Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Non-Hodgkin's Lymphoma in Spain
Total 0 results
Nothing found
Sponsors and Collaborators
Eurofins Genoma
Hospital ASEPEYO Sant Cugat
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
RMIT University, Melbourne, Australia
Everett Meyer
iCAD
ASST Cremona, Cremona
Kupfer, David J., M.D.
Hospital Durand, Argentina
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Nacuity Pharmaceuticals, Inc.
Neurophth Therapeutics Inc
Mª Victoria Maestre Sanchez
Alma Lasers Inc.
Aptis Medical
Apollo Neuroscience, Inc.
Korean Society of Spine Surgery
GFI
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Agency for Science, Technology and Research
View Full List
Medical Conditions
Luteal Phase Support
Chronic Constipation Symptoms
Metachronous Adenoma
Disorder of Fluid Balance
Scleredema
RISS Stage III Plasma Cell Myeloma
Recurrent Clear Cell Sarcoma of Soft Tissue
Rheumatoid Arthritis(RA)
Dienogest
Corneal Cross-Linking
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Immune-Mediated Inflammatory Disease
Splenic Trauma
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Fever
Gastric Cancer Stage IIIB-IIIC
T-LGL Leukemia
Major Liver Surgery
The Strength Properties of the Aorta in Vitro
Treatment Decisions
View Full List
Drug Interventions
MLN2480
Anticholinergic
TPN-101
Capecitabine and IMRT (if randomized to this arm)
Oxycodone/acetaminophen 5/325 mg
Olopatadine
Midazolam
Capecitabine/cisplatin
Intravenous Formulation of PD-0332991
Desvenlafaxine
PD-1/PD-L1 inhibitor
THC
Standard of care (SOC) for COVID-19
Intravenous deferiprone
Letrozole
OnabotulinumtoxinA
Camptosar
GLPG1837 multiple ascending doses
RDX227675
Fospropofol disodium, propofol
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Burundi
Contract Research Organizations in Gambia
Contract Research Organizations in Iran
Contract Research Organizations in Ireland
Contract Research Organizations in Luxembourg
Contract Research Organizations in Madagascar
Contract Research Organizations in Malta
Contract Research Organizations in Mauritania
Contract Research Organizations in Mexico
Contract Research Organizations in Montenegro
Contract Research Organizations in Netherlands
Contract Research Organizations in Venezuela
CRO list by country
CROs in Djibouti
SGS
All CROs in Djibouti
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe